In 2005, he joined Beijing Institute of Technology and was responsible for the teaching and research of medicinal chemistry. He is mainly engaged in the research of bioactive compounds in drug metabolites, and participates in the development of a national Class A new drug trbuterol and a series of generic drugs.

(1) Search for bioactive compounds from metabolites;
(2) Synthesis of complex compounds;
(3) Synthesis of isotopically labeled compounds.

1998/09 -- 2001/12 China Union Medical College, Medical Chemistry, Doctor
1995/09 -- 1998/07 Shenyang Pharmaceutical University, Master of Medicinal Chemistry
Sep. 1989 -- Jul. 1993, Shenyang Pharmaceutical University, Bachelor of Medicinal Chemistry

2005-present Associate Professor, School of Chemistry and Chemical Engineering, Beijing Institute of Technology
January 2003 -- December 2003 Postdoctoral Fellow, University of Hannover, Germany

Participated in the research and development of the national Class A new drug trbuterol, mainly responsible for the synthesis of phenylethanolamine compounds and the study of metabolites, Trbuterol has completed all clinical trials and is about to be launched. In recent years, the research and development of central nervous system drugs, including analgesic and anti-epileptic drugs, has published a number of high-level papers, been granted a number of patents, and presided over and participated in a number of major horizontal cooperation projects and national projects of enterprises.